I dont think anyone that has been around for awhile should be surprised they are continuing this suit. Besides being personal - it still has a very strong business case to seeing it through. They are still fiduciaries and charged with maintaining and increasing shareholder value. If they took the normal OTC route - they would have done multiple R/s and AS increases which would have eliminated all outside SHs. Insiders have anti dilution triggers protecring their holding. We do not.